These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6738374)

  • 21. [Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy. A follow up study].
    Ulrich LS; Wells M; Sturdee DW; Barlow DH; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    Ugeskr Laeger; 2003 Sep; 165(37):3530-2. PubMed ID: 14531356
    [No Abstract]   [Full Text] [Related]  

  • 22. Transdermal hormonal replacement therapy with transdermal progestin every second month.
    Lindgren R; Risberg B; Hammar M; Berg G
    Maturitas; 1995 Jun; 22(1):25-30. PubMed ID: 7666813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined estrogen and progestogen for the menopause.
    Mugglestone CJ; Swinhoe JR; Craft IL
    Acta Obstet Gynecol Scand; 1980; 59(4):327-9. PubMed ID: 7004052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
    Portman DJ; Symons JP; Wilborn W; Kempfert NJ
    Am J Obstet Gynecol; 2003 Feb; 188(2):334-42. PubMed ID: 12592236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
    Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
    Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute abdominal condition caused by retrograde bleeding in a postmenopausal patient on estrogen-progestogen therapy.
    Rabinovici J; Frenkel Y; Goldwasser B; Menczer J; Serr DM
    Am J Obstet Gynecol; 1985 Nov; 153(6):677-8. PubMed ID: 4061537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women.
    Jespersen CM; Arnung K; Hagen C; Hilden T; Nielsen F; Nielsen MD; Giese J
    J Hypertens; 1983 Dec; 1(4):361-4. PubMed ID: 6442719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women.
    Sturdee DW; Wade-Evans T; Paterson ME; Thom M; Studd JW
    Br Med J; 1978 Jun; 1(6127):1575-7. PubMed ID: 656818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
    Christiansen C; Riis BJ
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group.
    Bjarnason K; Cerin A; Lindgren R; Weber T
    Maturitas; 1999 Aug; 32(3):161-70. PubMed ID: 10515673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial effects of transdermal estradiol/norethisterone acetate.
    Lindgren R; Risberg B; Hammar M; Berg G; Pryse-Davies J
    Maturitas; 1992 Aug; 15(1):71-8. PubMed ID: 1528133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
    Jensen J; Nilas L; Christiansen C
    Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endometrial status of women on long-term continuous combined hormone replacement therapy.
    Hawthorn RJ; Spowart K; Walsh D; Hart DM
    Br J Obstet Gynaecol; 1991 Sep; 98(9):939-40. PubMed ID: 1911615
    [No Abstract]   [Full Text] [Related]  

  • 39. Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
    Whitehead MI; Lane G; Dyer G; Townsend PT; Collins WP; King RJ
    Br J Obstet Gynaecol; 1981 Sep; 88(9):914-8. PubMed ID: 7272264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of subcutaneous hormone implants during climacteric.
    Cardozo L; Gibb DM; Tuck SM; Thom MH; Studd JW; Cooper DJ
    Maturitas; 1984 Mar; 5(3):177-84. PubMed ID: 6727691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.